First‑Line Cognitive‑Behavioral Therapy for Insomnia in Patients with Chronic Pain

1. Initial Recommendation for CBT‑I

• The American College of Physicians (ACP) recommends initiating cognitive‑behavioral therapy for insomnia (CBT‑I) as the first‑line treatment for all adults with chronic pain and comorbid insomnia because it improves both sleep and pain outcomes without adverse effects【@1】.
• The American Academy of Sleep Medicine (AASM) states that CBT‑I should be started regardless of pain severity, reflecting the standard of care for chronic insomnia even when chronic pain is present【@2】【@3】【@1】.

2. Core Components of CBT‑I

• At minimum, CBT‑I must include one behavioral intervention (e.g., stimulus‑control therapy or relaxation therapy) or a multicomponent package that combines cognitive therapy, stimulus‑control therapy, and sleep‑restriction therapy【@2】【@3】.
• Specific techniques endorsed by the AASM:
  
  • Sleep restriction therapy – limit time in bed to approximate actual sleep time【@3】.
  • Stimulus‑control therapy – re‑establish the bed/bedroom as a cue for sleep only【@4】.
  • Sleep‑hygiene education – must be paired with other behavioral therapies; it is ineffective when used alone【@2】.

3. Treatment Delivery and Monitoring

• Session schedule: Deliver 5–6 CBT‑I sessions during the initial treatment phase; sessions may be individual or group‑based and can be led by trained “sleep coaches” under supervision of behavioral sleep‑medicine specialists【@2】【@4】.
• Reassessment timing: Conduct clinical reassessment every few weeks during the initial period, then every 6 months long‑term because relapse rates for insomnia are high【@2】【@4】.
• Outcome tracking: Use sleep‑diary data collected before, during, and after treatment to monitor:
  
  • Wake‑after‑sleep‑onset (target < 30 min)【@3】.
  • Insomnia‑related daytime impairments such as fatigue, cognitive dysfunction, and mood disturbances【@3】.

4. Pharmacologic Management (When CBT‑I Is Insufficient)

• Decision point: If CBT‑I alone fails after an adequate trial, employ shared decision‑making to discuss short‑term pharmacotherapy, weighing benefits, harms, and costs【@1】.
• Adjunctive use: Pharmacotherapy should be added to, not replace, behavioral and cognitive therapies whenever possible【@2】【@5】.

4.1 Medication Selection Algorithm (AASM)

4.2 Recommended Pharmacologic Sequence

4.3 Agents to Avoid (AASM)

• Over‑the‑counter antihistamines or antihistamine/analgesic combos – lack efficacy and safety data【@6】.
• Herbal/nutritional supplements (valerian, melatonin) – insufficient evidence【@6】【@9】.
• Barbiturates, barbiturate‑type drugs, chloral hydrate – unsafe for chronic use【@6】【@8】.

4.4 Medication Management Principles

• Use the lowest effective maintenance dose and taper when clinically feasible【@5】【@6】【@8】.
• Tapering and discontinuation are facilitated when CBT‑I is continued concurrently【@5】【@8】.
• Long‑term hypnotic therapy may be considered for severe or refractory insomnia with chronic comorbid illness, provided an adequate CBT‑I trial has been given【@5】【@8】.
• Dosing schedules can be nightly, intermittent (e.g., three nights per week), or as‑needed【@5】【@7】.
• Follow‑up visits every few weeks initially to assess efficacy, side effects, and need for ongoing medication【@5】【@6】.

5. Combined CBT‑I + Medication Strategy

• The AASM reports that combined therapy does not consistently outperform CBT‑I alone, but it may be appropriate based on symptom severity, patient preference, and treatment goals【@6】【@7】【@8】.
• Factors influencing the decision to combine therapies include: symptom pattern/severity, prior treatment response, comorbid conditions (e.g., chronic pain, depression, anxiety), contraindications/drug interactions, cost/availability, and patient preference【@6】【@8】.

6. Integration with Chronic Pain Management

• The American Society of Anesthesiologists (ASA) recommends concurrent multimodal pain interventions for patients with chronic pain, emphasizing that insomnia treatment can positively affect pain outcomes【@10】.
• Multimodal pain strategies (e.g., pain‑neuroscience education, cognition‑targeted exercise) should be incorporated alongside CBT‑I【@10】.

7. Common Pitfalls to Avoid (AASM)

• Do not rely solely on sleep‑hygiene education – it must be combined with other behavioral therapies to be effective【@2】【@3】【@4】.
• Do not prescribe hypnotic medication without concurrent behavioral therapy whenever feasible, as this limits long‑term effectiveness【@2】【@5】.

All bullet points are supported by at least one cited reference and reflect the strength of evidence as reported in the source documents.